30/05/2017 With reference to the agreement signed on 19/04/2017 with the Greek company DEMO SA, C.F.I. SRL has launched Deferoxamine Noridem 2 g in the Italian market. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.
C.F.I. SRL on May 2017 presents and inaugurates the new website in a more modern and contemporary version, with a layout compatible with most browsers and smartphones.